Most new companies are faced with the dual hurdle of developing their capabilities while dealing with financial constraints of not having an established revenue stream. This is especially true in the Biotechnology industry, where technological competence in research is a key success factor, but the benefits of research are often not realized for over a decade. This study uses a system dynamics framework to investigate viable growth strategies for a young biopharmaceutical research company in terms of the expansion of both its technology platform, as well as its proprietary programs.
展开▼
